920 related articles for article (PubMed ID: 15386591)
21. Aberrant Epstein-Barr virus persistence in HIV carriers is characterized by anti-Epstein-Barr virus IgA and high cellular viral loads with restricted transcription.
Stevens SJ; Smits PH; Verkuijlen SA; Rockx DA; van Gorp EC; Mulder JW; Middeldorp JM
AIDS; 2007 Oct; 21(16):2141-9. PubMed ID: 18090040
[TBL] [Abstract][Full Text] [Related]
22. Multiplex-nested RT-PCR to evaluate latent and lytic Epstein Barr virus gene expression.
Bergallo M; Costa C; Baro S; Musso T; Balbo L; Merlino C; Cavallo R
J Biotechnol; 2007 Feb; 128(3):462-76. PubMed ID: 17147963
[TBL] [Abstract][Full Text] [Related]
23. BZLF1 controlled by family repeat domain induces lytic cytotoxicity in Epstein-Barr virus-positive tumor cells.
Wang H; Zhao Y; Zeng L; Tang M; El-Deeb A; Li JJ; Cao Y
Anticancer Res; 2004; 24(1):67-74. PubMed ID: 15015577
[TBL] [Abstract][Full Text] [Related]
24. Persistent productive Epstein-Barr virus replication in normal epithelial cells in vivo.
Walling DM; Flaitz CM; Nichols CM; Hudnall SD; Adler-Storthz K
J Infect Dis; 2001 Dec; 184(12):1499-507. PubMed ID: 11740724
[TBL] [Abstract][Full Text] [Related]
25. Cellular microRNAs 200b and 429 regulate the Epstein-Barr virus switch between latency and lytic replication.
Ellis-Connell AL; Iempridee T; Xu I; Mertz JE
J Virol; 2010 Oct; 84(19):10329-43. PubMed ID: 20668090
[TBL] [Abstract][Full Text] [Related]
26. Low level of lytic replication in a recombinant Epstein-Barr virus carrying an origin of replication devoid of BZLF1-binding sites.
Feederle R; Delecluse HJ
J Virol; 2004 Nov; 78(21):12082-4. PubMed ID: 15479851
[TBL] [Abstract][Full Text] [Related]
27. In vivo dynamics of EBNA1-oriP interaction during latent and lytic replication of Epstein-Barr virus.
Daikoku T; Kudoh A; Fujita M; Sugaya Y; Isomura H; Tsurumi T
J Biol Chem; 2004 Dec; 279(52):54817-25. PubMed ID: 15498777
[TBL] [Abstract][Full Text] [Related]
28. Efficient Translation of Epstein-Barr Virus (EBV) DNA Polymerase Contributes to the Enhanced Lytic Replication Phenotype of M81 EBV.
Church TM; Verma D; Thompson J; Swaminathan S
J Virol; 2018 Mar; 92(6):. PubMed ID: 29263273
[TBL] [Abstract][Full Text] [Related]
29. One-step multiplex real-time PCR assay to analyse the latency patterns of Epstein-Barr virus infection.
Kubota N; Wada K; Ito Y; Shimoyama Y; Nakamura S; Nishiyama Y; Kimura H
J Virol Methods; 2008 Jan; 147(1):26-36. PubMed ID: 17870188
[TBL] [Abstract][Full Text] [Related]
30. Interferon-γ-inducible protein 16 (IFI16) is required for the maintenance of Epstein-Barr virus latency.
Pisano G; Roy A; Ahmed Ansari M; Kumar B; Chikoti L; Chandran B
Virol J; 2017 Nov; 14(1):221. PubMed ID: 29132393
[TBL] [Abstract][Full Text] [Related]
31. Structural basis of lytic cycle activation by the Epstein-Barr virus ZEBRA protein.
Petosa C; Morand P; Baudin F; Moulin M; Artero JB; Müller CW
Mol Cell; 2006 Feb; 21(4):565-72. PubMed ID: 16483937
[TBL] [Abstract][Full Text] [Related]
32. [Molecular mechanism of Epstein-barr virus DNA replication].
Tsurumi T
Uirusu; 2002 Jun; 52(1):191-201. PubMed ID: 12227172
[No Abstract] [Full Text] [Related]
33. Multiple roles of Epstein-Barr virus SM protein in lytic replication.
Han Z; Marendy E; Wang YD; Yuan J; Sample JT; Swaminathan S
J Virol; 2007 Apr; 81(8):4058-69. PubMed ID: 17287267
[TBL] [Abstract][Full Text] [Related]
34. Requirement of replication licensing for the dyad symmetry element-dependent replication of the Epstein-Barr virus oriP minichromosome.
Shirakata M; Imadome KI; Hirai K
Virology; 1999 Oct; 263(1):42-54. PubMed ID: 10544081
[TBL] [Abstract][Full Text] [Related]
35. Epstein-Barr virus permissively infects human syncytiotrophoblasts in vitro and induces replication of human T cell leukemia-lymphoma virus type I in dually infected cells.
Tóth FD; Aboagye-Mathiesen G; Nemes J; Liu X; Andirkó I; Hager H; Zdravkovic M; Szabó J; Kiss J; Aranyosi J; Ebbesen P
Virology; 1997 Mar; 229(2):400-14. PubMed ID: 9126252
[TBL] [Abstract][Full Text] [Related]
36. Genome-wide transcription program and expression of the Rta responsive gene of Epstein-Barr virus.
Lu CC; Jeng YY; Tsai CH; Liu MY; Yeh SW; Hsu TY; Chen MR
Virology; 2006 Feb; 345(2):358-72. PubMed ID: 16298410
[TBL] [Abstract][Full Text] [Related]
37. Activation of oriLyt, the lytic origin of DNA replication of Epstein-Barr virus, by BZLF1.
Schepers A; Pich D; Hammerschmidt W
Virology; 1996 Jun; 220(2):367-76. PubMed ID: 8661388
[TBL] [Abstract][Full Text] [Related]
38. DNA Damage Signaling Is Induced in the Absence of Epstein-Barr Virus (EBV) Lytic DNA Replication and in Response to Expression of ZEBRA.
Wang'ondu R; Teal S; Park R; Heston L; Delecluse H; Miller G
PLoS One; 2015; 10(5):e0126088. PubMed ID: 25950714
[TBL] [Abstract][Full Text] [Related]
39. Reactivation of lytic replication from B cells latently infected with Epstein-Barr virus occurs with high S-phase cyclin-dependent kinase activity while inhibiting cellular DNA replication.
Kudoh A; Fujita M; Kiyono T; Kuzushima K; Sugaya Y; Izuta S; Nishiyama Y; Tsurumi T
J Virol; 2003 Jan; 77(2):851-61. PubMed ID: 12502801
[TBL] [Abstract][Full Text] [Related]
40. Initiation of DNA replication within oriP is dispensable for stable replication of the latent Epstein-Barr virus chromosome after infection of established cell lines.
Norio P; Schildkraut CL; Yates JL
J Virol; 2000 Sep; 74(18):8563-74. PubMed ID: 10954558
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]